Associated Papers
The genetics of portal hypertension: Recent developments and the road ahead.
Shalaby S et al.
Liver International : Official Journal of the International Association for the Study of the Liver, 2023
Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels.
Nam YW et al.
Acta Pharmacologica Sinica, 2023
KCa-Related Neurological Disorders: Phenotypic Spectrum and Therapeutic Indications.
Zahra A et al.
Current Neuropharmacology, 2023
Channelopathy-causing mutations in the S45A/S45B and HA/HB helices of KCa2.3 and KCa3.1 channels alter their apparent Ca2+ sensitivity.
Orfali R et al.
Cell Calcium, 2022
Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.
Bauer CK et al.
American Journal of Human Genetics, 2019
A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension.
Koot BG et al.
Journal of Hepatology, 2016
Select a paper to view details